At3g24513 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At3g24513 antibody; MOB24 antibody; Putative defensin-like protein 258 antibody
Target Names
At3g24513
Uniprot No.

Target Background

Database Links

KEGG: ath:AT3G24513

STRING: 3702.AT3G24513.1

UniGene: At.63249

Protein Families
DEFL family
Subcellular Location
Secreted.

Q&A

What is the At3g24513 gene and what type of protein does it encode?

At3g24513 is a gene located on chromosome 3 of Arabidopsis thaliana. Following the standard Arabidopsis gene nomenclature, "At" designates Arabidopsis thaliana, "3" indicates chromosome 3, and "g24513" represents its unique five-digit numerical identifier reflecting its chromosomal position . The protein encoded by this gene requires specific antibody generation strategies due to its plant-specific characteristics and expression patterns. Understanding the protein's structure, function, and expression patterns is essential before attempting antibody-based experiments.

What antibody classes are most effective for Arabidopsis protein detection?

For plant protein detection, IgG antibodies are generally preferred due to their specificity and stability. While commercial antibodies against Arabidopsis proteins frequently use IgG1 or IgG2 subclasses, IgG3 offers potential advantages for certain applications. IgG3 possesses high affinity for activating Fcγ receptors, effective complement fixation, and a long hinge structure that may be better suited for detecting low-abundance targets like many plant proteins . Consider the following comparison when selecting antibody classes:

Antibody ClassAdvantages for Plant Protein DetectionPotential Limitations
IgG1Stable, widely availableMay have limited sensitivity for low-abundance proteins
IgG2Good specificity, low backgroundPotentially reduced binding efficiency
IgG3High affinity, better for low-abundance targets, long hingeHistorically less common in commercial preparations
MonoclonalHigh specificity, consistent resultsMay recognize limited epitopes
PolyclonalRecognizes multiple epitopes, robust signalPotential for cross-reactivity

How can I validate the specificity of an At3g24513 antibody?

Antibody validation is critical for ensuring experimental reliability. A comprehensive validation approach should include:

  • Western blot analysis using:

    • Wild-type Arabidopsis tissue expressing At3g24513

    • Negative controls using T-DNA insertion or CRISPR/Cas9 knockout lines of At3g24513

    • Recombinant At3g24513 protein as a positive control

  • Immunoprecipitation followed by mass spectrometry to confirm the antibody pulls down the correct protein

  • Immunohistochemistry comparing signal patterns to known expression profiles

  • Comparison of results across multiple antibody lots and sources if available

Document band patterns, molecular weights, and signal intensities systematically to establish a validation profile for your specific experimental conditions.

How should I design experiments to evaluate At3g24513 protein expression under different conditions?

A robust experimental design for studying At3g24513 expression requires careful consideration of variables, controls, and measurement approaches . Follow these methodological steps:

  • Define your variables clearly:

    • Independent variable: The condition you're manipulating (e.g., temperature, light exposure, hormone treatment)

    • Dependent variable: At3g24513 protein levels as measured by antibody detection

    • Control variables: Growth conditions, developmental stage, tissue type

  • Include appropriate controls:

    • Positive control: Tissue known to express At3g24513

    • Negative control: At3g24513 knockout line

    • Loading control: Detection of a constitutively expressed protein (e.g., actin, tubulin)

  • Use quantitative methods:

    • Densitometry for western blot analysis

    • Fluorescence intensity measurements for immunofluorescence

    • ELISA for quantitative protein measurements

  • Perform biological and technical replicates:

    • Minimum three biological replicates from independent plants

    • At least two technical replicates per biological sample

What is the optimal tissue extraction protocol for detecting At3g24513 with antibodies?

The extraction protocol significantly impacts antibody detection success. For Arabidopsis proteins:

  • Harvest tissue rapidly and flash-freeze in liquid nitrogen to preserve protein integrity.

  • Use a plant-optimized extraction buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100 or NP-40

    • 0.5% sodium deoxycholate

    • Protease inhibitor cocktail optimized for plant samples

    • Optional: phosphatase inhibitors if studying phosphorylation states

  • Homogenize thoroughly using mechanical disruption (e.g., bead beater, mortar and pestle).

  • Clarify by centrifugation (15,000 × g, 15 minutes, 4°C).

  • Quantify protein concentration using Bradford or BCA assay.

  • Add reducing sample buffer and heat at 70°C (not boiling) for 10 minutes to preserve epitope structure.

This protocol may require optimization depending on the subcellular localization and biochemical properties of the At3g24513 protein.

How can I optimize immunolocalization studies for At3g24513 in different plant tissues?

Immunolocalization requires specialized approaches for plant tissues due to cell wall barriers and autofluorescence concerns:

  • Fixation options:

    • 4% paraformaldehyde for standard fixation

    • Ethanol:acetic acid (3:1) for preserving certain epitopes

    • Optimize fixation time (typically 1-4 hours) to balance tissue preservation and antibody accessibility

  • Permeabilization strategies:

    • Cell wall digestion with pectolyase and cellulase

    • Detergent treatment (0.1-0.5% Triton X-100)

    • Freeze-shattering for recalcitrant tissues

  • Blocking recommendations:

    • 3-5% BSA or normal serum from the species of secondary antibody

    • Addition of 0.1% cold fish skin gelatin to reduce plant-specific background

  • Signal detection optimization:

    • Confocal microscopy with settings to minimize plant autofluorescence

    • Sequential scanning to separate antibody signal from autofluorescence

    • Consider the use of quantum dots or alternative fluorophores less affected by autofluorescence

How do I interpret contradictory results when using At3g24513 antibodies?

Contradictory results are common in antibody-based research. Address discrepancies through systematic troubleshooting:

  • Antibody validation assessment:

    • Verify antibody specificity through knockout/knockdown controls

    • Check epitope locations - different antibodies may recognize different protein regions

    • Evaluate potential post-translational modifications that might mask epitopes

  • Technical variables to check:

    • Protein extraction method differences

    • Antibody lot-to-lot variation

    • Sample storage conditions and freeze-thaw cycles

    • Detection system sensitivity and dynamic range

  • Biological variation sources:

    • Different Arabidopsis ecotypes/accessions showing genetic variation

    • Developmental stage differences

    • Growth condition variations

    • Circadian or temporal expression patterns

  • Methodological triangulation:

    • Confirm results using alternative techniques (e.g., mass spectrometry)

    • Correlate with transcript levels by RT-PCR or RNA-seq

    • Use epitope-tagged versions of the protein for validation

What approaches can I use when At3g24513 antibodies show non-specific binding?

Non-specific binding is a common challenge with plant protein antibodies. Address it through these methodological improvements:

  • Optimize blocking conditions:

    • Extend blocking time (1-3 hours at room temperature or overnight at 4°C)

    • Test different blocking agents (BSA, milk, normal serum, plant-specific blockers)

    • Include 0.1-0.2% Tween-20 in washing and antibody incubation buffers

  • Antibody dilution optimization:

    • Perform titration experiments testing serial dilutions

    • Balance signal-to-noise ratio against sensitivity requirements

    • Consider longer incubation times at higher dilutions

  • Pre-adsorption techniques:

    • Incubate antibody with tissue from knockout plants to remove cross-reactive antibodies

    • Use acetone powder from non-target tissues for pre-clearing

  • Alternative antibody approaches:

    • Consider using epitope tagging approaches with well-validated tag antibodies

    • Explore CRISPR/Cas9 knock-in of tags if antibody problems persist

How should I quantify At3g24513 protein levels from western blot data?

Quantitative analysis of western blots requires rigorous methodology:

  • Image acquisition parameters:

    • Capture images within the linear dynamic range of your detection system

    • Use consistent exposure settings across all compared samples

    • Include a dilution series of a reference sample to confirm linearity

  • Normalization approaches:

    • Use loading controls (e.g., GAPDH, actin, tubulin) appropriate for your experimental conditions

    • Consider total protein normalization (e.g., Ponceau S, Coomassie staining)

    • Verify that normalization controls are stable under your experimental conditions

  • Quantification methods:

    • Use densitometry software with background subtraction

    • Define consistent measurement areas across all bands

    • Apply rolling ball background correction for uneven backgrounds

  • Statistical analysis:

    • Compare biological replicates (n≥3) rather than technical replicates

    • Apply appropriate statistical tests based on data distribution

    • Report fold-changes relative to control conditions with statistical significance

What considerations are important when using At3g24513 antibodies for co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) with plant proteins requires specialized approaches:

  • Extraction buffer optimization:

    • Test different detergent types and concentrations to preserve protein-protein interactions

    • Include stabilizing agents (e.g., glycerol, low concentrations of specific salts)

    • Consider crosslinking approaches for transient interactions

  • Co-IP procedure recommendations:

    • Pre-clear lysates with beads alone to reduce non-specific binding

    • Use antibody amounts determined by titration experiments

    • Include IgG control immunoprecipitations

    • Consider tandem purification approaches for increased specificity

  • Validation requirements:

    • Confirm reciprocal Co-IP when possible

    • Verify interactions using alternative methods (e.g., yeast two-hybrid, FRET)

    • Include negative controls (unrelated proteins, non-interacting mutants)

  • Analysis approaches:

    • Use mass spectrometry to identify novel interaction partners

    • Quantify interaction strengths under different conditions

    • Map interaction domains through truncation or point mutations

How can I determine if post-translational modifications affect At3g24513 antibody recognition?

Post-translational modifications (PTMs) can significantly alter antibody recognition:

  • PTM prediction and analysis:

    • Use bioinformatic tools to predict potential modification sites

    • Generate samples with induced or blocked modifications

    • Test antibody recognition under conditions known to alter PTMs (e.g., phosphatase treatment)

  • Experimental approaches:

    • Compare recognition patterns before and after phosphatase treatment

    • Use Phos-tag gels to separate phosphorylated from non-phosphorylated forms

    • Test recognition after deglycosylation treatments if glycosylation is predicted

  • Antibody selection considerations:

    • Determine if antibody epitope contains potential modification sites

    • Consider using multiple antibodies recognizing different regions

    • For critical experiments, use modification-specific antibodies if available

  • Complementary techniques:

    • Use mass spectrometry to map actual modification sites

    • Correlate antibody recognition with modification states

    • Generate site-specific mutations to test modification effects

How can At3g24513 antibodies be combined with proteomics approaches for comprehensive analysis?

Integrating antibody-based detection with proteomics creates powerful research opportunities:

  • Immunoprecipitation-mass spectrometry (IP-MS) workflow:

    • Optimize IP conditions for maximum specificity and yield

    • Process samples using MS-compatible protocols (avoid detergents like SDS)

    • Include appropriate controls (IgG IP, knockout line IP)

    • Use label-free or labeled quantification methods for comparative studies

  • Proximity labeling approaches:

    • Consider fusion of BioID or APEX2 to At3g24513

    • Use antibodies to verify fusion protein expression and localization

    • Optimize labeling conditions for plant tissues

    • Analyze labeled proteins by affinity purification and MS

  • Protein complex analysis:

    • Combine antibody purification with native-PAGE

    • Use mild extraction conditions to preserve complexes

    • Consider size exclusion chromatography after IP

    • Cross-validate complex components through multiple approaches

  • Modification-specific proteomics:

    • Enrich for specific modifications using antibodies

    • Correlate modification patterns with protein function

    • Map modification networks under different conditions

What approaches can I use to study At3g24513 in specialized cell types or developmental stages?

Studying proteins in specific contexts requires specialized methods:

  • Cell type-specific analysis:

    • Combine antibody detection with fluorescence-activated cell sorting (FACS)

    • Use laser capture microdissection followed by immunoblotting

    • Implement cell type-specific promoters for tagged protein expression

  • Developmental time course analysis:

    • Standardize tissue collection across developmental stages

    • Use normalized loading based on cell number or tissue weight

    • Consider developmental markers as internal controls

    • Develop a quantitative timeline of expression patterns

  • Inducible systems for temporal control:

    • Use inducible promoters (e.g., dexamethasone, estradiol) for controlled expression

    • Combine antibody detection with time-course sampling

    • Monitor protein accumulation, localization, and modification dynamics

  • Single-cell approaches:

    • Optimize immunofluorescence protocols for single-cell resolution

    • Consider expansion microscopy for enhanced spatial resolution

    • Correlate protein patterns with cell-specific transcriptomics

How can I implement a comparative analysis of At3g24513 across different Arabidopsis ecotypes?

Natural variation studies provide insights into protein function and adaptation:

  • Ecotype selection considerations:

    • Include diverse geographical origins

    • Consider ecotypes with phenotypic differences relevant to At3g24513 function

    • Include well-characterized ecotypes (Col-0, Ler, Ws) as references

  • Sequence analysis requirements:

    • Check for polymorphisms in the coding sequence across ecotypes

    • Verify if antibody epitope regions are conserved

    • Consider using multiple antibodies targeting different regions

  • Expression analysis methodology:

    • Standardize growth conditions precisely across all ecotypes

    • Ensure equivalent developmental stages despite different growth rates

    • Use appropriate loading controls that are stable across ecotypes

  • Phenotypic correlation approaches:

    • Correlate protein expression/modification patterns with ecotype-specific traits

    • Consider association analysis for natural variation studies

    • Validate functional differences through complementation studies

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.